Miura Takashi, Tanigawa Kazuyoshi, Matsukuma Seiji, Matsumaru Ichiro, Hisatomi Kazuki, Hazama Shiro, Tsuneto Akira, Eishi Kiyoyuki
Department of Cardiovascular Surgery, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, 852-8501, Japan.
Department of Cardiovascular Surgery, Sasebo General Hospital, Nagasaki, Japan.
Gen Thorac Cardiovasc Surg. 2016 Jun;64(6):315-24. doi: 10.1007/s11748-016-0638-z. Epub 2016 Mar 11.
To compare the outcomes of mitral and/or tricuspid valve surgery in patients with previous sternotomy between those who underwent a right thoracotomy and those who underwent re-sternotomy.
Between October 2009 and May 2015, eighteen patients underwent a right thoracotomy (R group) and 28 underwent re-sternotomy (re-S group). The right thoracotomy was prioritized for previous coronary artery bypass grafting. Follow-up was 100 % complete with a mean follow-up of 1.9 ± 1.5 years for the R group and 2.5 ± 1.4 years for the re-S group (p = 0.2137).
Hypothermic ventricular fibrillation was applied in 33.3 % in the R group and in 7.1 % in the re-S group (p = 0.0424). Hospital mortality, the median intensive care unit stay, and the median postoperative hospital stay were 0 % versus 7.1 % (p = 0.5130), 3 days versus 2 days (p = 0.2370), and 28 days versus 29.5 days (p = 0.8043) for the R group versus the re-S group, respectively. Although the rate of major complications was comparable (R group 33.3 % versus re-S group 25.0 %, p = 0.5401), those contents were not equal. Deep sternum infection developed only in the re-S group (3.6 %) and reoperation for bleeding was required only in the R group (11.1 %). No significant difference was observed in the 2-year cardiac-related mortality-free rate (R group 93.3 ± 6.4 % versus re-S group 90.8 ± 6.4 %, p = 0.7516).
Given study limitations, the right thoracotomy approach after previous sternotomy provided favorable outcomes as well as re-sternotomy. When selecting a right thoracotomy for re-do mitral and/or tricuspid surgery, the surgical strategy needs to be thoroughly planned.
比较曾行胸骨切开术的患者在接受右胸切开术和再次胸骨切开术时二尖瓣和/或三尖瓣手术的结果。
2009年10月至2015年5月期间,18例患者接受了右胸切开术(R组),28例接受了再次胸骨切开术(再次胸骨切开术组)。对于既往有冠状动脉旁路移植术的患者优先选择右胸切开术。随访率为100%,R组平均随访1.9±1.5年,再次胸骨切开术组平均随访2.5±1.4年(p = 0.2137)。
R组33.3%的患者应用了低温室颤,再次胸骨切开术组为7.1%(p = 0.0424)。R组与再次胸骨切开术组的医院死亡率、重症监护病房住院时间中位数和术后住院时间中位数分别为0%对7.1%(p = 0.5130)、3天对2天(p = 0.2370)、28天对29.5天(p = 0.8043)。虽然主要并发症发生率相当(R组33.3%对再次胸骨切开术组25.0%,p = 0.5401),但其内容并不相同。仅在再次胸骨切开术组发生了深部胸骨感染(3.6%),仅在R组需要因出血进行再次手术(11.1%)。两组2年无心脏相关死亡率无显著差异(R组93.3±6.4%对再次胸骨切开术组90.8±6.4%,p = 0.7516)。
考虑到研究局限性,既往胸骨切开术后采用右胸切开术与再次胸骨切开术一样能提供良好的结果。在选择右胸切开术进行再次二尖瓣和/或三尖瓣手术时,需要全面规划手术策略。